Open access
86
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
Gang Wang1 Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China;2 China Clinical Research Center for Mental Disorders, Beijing, People’s Republic of China;3 Center of Depression, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China
, Yan Cheng4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of ChinaCorrespondence[email protected]
, Jia Ning Wang4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of China
, Sheng Hu Wu4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of China
& Hai Bo Xue5 UCB (Zhuhai) Pharma Co., Ltd., Shanghai, People’s Republic of China
Pages 2077-2087
|
Published online: 22 Aug 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.